Assignee
NIITSU YOSHIRO
JP·9 granted patents·5 pending applications·196 citations·filing 2005–2018
Top patents by PatentIndex Score
14 records- 0196US9393315B2Compounds for targeting drug delivery and enhancing siRNA activityNIITSU YOSHIRO·Filed 2012·Granted Jul 19, 2016·12 cites·17 claims
- 0296US9011903B2Cationic lipids for therapeutic agent delivery formulationsNIITSU YOSHIRO·Filed 2012·Granted Apr 21, 2015·26 cites·23 claims
- 0395US8741867B2Retinoid-liposomes for treating fibrosisNIITSU YOSHIRO·Filed 2012·Granted Jun 3, 2014·34 cites·29 claims
- 0495US8664376B2Retinoid-liposomes for enhancing modulation of HSP47 expressionNIITSU YOSHIRO·Filed 2012·Granted Mar 4, 2014·30 cites·26 claims
- 0595US8173170B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2005·Granted May 8, 2012·32 cites·10 claims
- 0694US8178124B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2011·Granted May 15, 2012·20 cites·14 claims
- 0793US8686052B2Targeting agent for cancer cell or cancer-associated fibroblastNIITSU YOSHIRO·Filed 2008·Granted Apr 1, 2014·32 cites·5 claims
- 0890US8652526B2Drug carrier and drug carrier kit for inhibiting fibrosisNIITSU YOSHIRO·Filed 2012·Granted Feb 18, 2014·10 cites·8 claims
- 0955US2012328694A1Therapeutic agent for fibroid lungNIITSU YOSHIRO·Filed 2012·Application pending·0 cites
- 1052US2012269886A1Therapeutic agent for pulmonary fibrosisNIITSU YOSHIRO·Filed 2012·Application pending·0 cites
- 1150US2020370050A1Cell proliferation inhibitor and cancer treatment or prevention pharmaceutical composition including cell proliferation inhibitorNIITSU YOSHIRO·Filed 2018·Application pending·0 cites
- 1242US9408864B2Composition for regenerating normal tissue from fibrotic tissueNIITSU YOSHIRO·Filed 2011·Granted Aug 9, 2016·0 cites·8 claims
- 1340US2013136789A1Agent for treating renal fibrosisNIITSU YOSHIRO·Filed 2011·Application pending·0 cites
- 1433US2014315975A1Apoptosis-inducing agentNIITSU YOSHIRO·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →